evidence table
Moringa Blood Glucose Meta-Analysis Evidence Table
Structured evidence table for Moringa Blood Glucose Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Moringa Blood Glucose Meta-Analysis | According to the World Health Organization of 2025, the NCDs remain a global health burden that increases the risk of mortality []. | 1 | Mokgalaboni Kabelo (2026) | Moringa oleifera on hyperglycemia and hypertension in metabolic diseases: Systematic review, exploratory meta-analysis and meta-regression |
| Moringa Blood Glucose Meta-Analysis | Among widely available standard treatments is Glucophage, such as metformin, and its long-term use is associated with lactic acidosis, hypoglycemia, and vitamin Bdeficiency, and the latter promotes neuropathy [,,,]. | 1 | Mokgalaboni Kabelo (2026) | Moringa oleifera on hyperglycemia and hypertension in metabolic diseases: Systematic review, exploratory meta-analysis and meta-regression |
| Moringa Blood Glucose Meta-Analysis | However, some of this evidence was obtained from preclinical studies, which remain plausible in terms of translatability into clinical settings. | 1 | Mokgalaboni Kabelo (2026) | Moringa oleifera on hyperglycemia and hypertension in metabolic diseases: Systematic review, exploratory meta-analysis and meta-regression |
| Moringa Blood Glucose Meta-Analysis | 1 [2] [3] [4] [5] [6] [7] [8] [8] [9] [10] Metabolic disease is a class of non-communicable diseases (NCDs) that includes obesity, high blood pressure, dyslipidemia, and diabetes. | 1 | Mokgalaboni Kabelo (2026) | Moringa oleifera on hyperglycemia and hypertension in metabolic diseases: Systematic review, exploratory meta-analysis and meta-regression |
| Moringa Blood Glucose Meta-Analysis | No systematic research critically evaluated its impact on cardiometabolic outcomes assessed through randomized controlled trials (RCTs), thus this study aimed to do so by synthesizing existing evidence. | 1 | Crișan D (2025) | Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. |
| Moringa Blood Glucose Meta-Analysis | Random-effects meta-analyses were performed using standardized mean differences, risk of bias was assessed using the Cochrane RoB 2 tool, while the certainty of evidence was evaluated using GRADE assessment. | 1 | Crișan D (2025) | Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. |
| Moringa Blood Glucose Meta-Analysis | Subgroup analyses suggested potential benefits at doses I 2 frequently >80% for anthropometric and lipid parameters), indirectness, and methodological limitations reduced the overall certainty of evidence to very low for all the evaluated outcomes. | 1 | Crișan D (2025) | Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. |
| Moringa Blood Glucose Meta-Analysis | is traditionally used in African and Asian medicine for its nutritional and therapeutic properties. | 1 | Crișan D (2025) | Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. |
Source documents
- Moringa oleifera on hyperglycemia and hypertension in metabolic diseases: Systematic review, exploratory meta-analysis and meta-regression
- Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment.